By Stem Cells Translational Medicine –
Our study demonstrates the advantage of using genetically immunodeficient rodents over traditional pharmacological methods in cell therapy research for spinal cord injury (SCI). This approach preserves the integrity and functionality of neural progenitor cells, which are essential for successful neurogenesis and neuron development. This advancement not only enhances the reliability and effectiveness of future SCI treatments but also sets a new standard in preclinical testing of regenerative medicine. Our findings have far-reaching implications, offering a promising path towards more effective and efficient therapies for SCI and potentially other neurological disorders.
